That limits the ability of producers to grow, although low-cost operators like Antero can still theoretically take share. However, Antero has been more interested in merely maintaining its output and ...
Mark Sabag, Executive Vice President of International Markets Commercial at Teva Pharmaceutical Industries Ltd. (NYSE:TEVA), recently sold a substantial block of the company's ordinary shares. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results